Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT)

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages 974-980

  Stephans, Kevin L ^a   Djemil, Toufik ^a   Tendulkar, Rahul D ^a   Robinson, Cliff G ^b   Reddy, Chandana A ^a   Videtic, Gregory M M ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b USA   (United States)

Author keywords

Chest wall toxicity; Lung cancer; SBRT; Stage I; Stereotactic body radiotherapy

Indexed keywords

BODY MASS INDEX; CHEST WALL; GROSS TUMOR VOLUME; LUNG CANCER; MULTI VARIATE ANALYSIS; ODDS RATIOS; PERIPHERAL VASCULAR DISEASE; PLANNING TARGET VOLUMES; RADIATION THERAPY ONCOLOGY GROUPS; SBRT; STATISTICAL SIGNIFICANCE; STEREOTACTIC BODY RADIOTHERAPY; TUMOR SIZE; TUMOR VOLUMES;

BIOLOGICAL ORGANS; MULTIVARIANT ANALYSIS; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

TOXICITY;

NARCOTIC AGENT;

ADULT; AGED; ARTICLE; CANCER SIZE; CHEST WALL TOXICITY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; PAIN; PREDICTION; PRIORITY JOURNAL; RADIATION HAZARD; RADIATION INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SMOKING; STEREOTACTIC BODY RADIATION THERAPY; THORAX DISEASE; THORAX WALL; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; RADIATION INJURIES; RADIOSURGERY; RETROSPECTIVE STUDIES; SMOKING; THORACIC WALL; TIME FACTORS; TUMOR BURDEN;

EID: 81755180013     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.12.002     Document Type: Article

References (26)

1. P. Baumann, J. Nyman, and I. Lax Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries Acta Oncol 45 2006 787 795
2. J.J. Beitler, E.A. Badine, and D. El-Sayah Stereotactic body radiation therapy for nonmetastatic lung cancer: An analysis of 75 patients treated over 5 years Int J Radiat Oncol Biol Phys 65 2006 100 106
3. M. Guckenberger, J. Wulf, and G. Mueller Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: Relevance of 4D dose calculation Int J Radiat Oncol Biol Phys 74 2009 47 54
4. F.J. Lagerwaard, C.J. Haasbeek, and E.F. Smit Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
5. R. McCammon, T.E. Schefter, and L.E. Gaspar Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 73 2009 112 118
6. Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431
7. A.W. Ng, S.Y. Tung, and V.Y. Wong Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer - Report on clinical outcome and dose to critical organs Radiother Oncol 87 2008 24 28
8. J. Nyman, K.A. Johansson, and U. Hulten Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer - Mature results for medically inoperable patients Lung Cancer 51 2006 97 103
9. P. Okunieff, A.L. Petersen, and A. Philip Stereotactic Body Radiation Therapy (SBRT) for lung metastases Acta Oncol 45 2006 808 817
10. R. Onimaru, H. Shirato, and S. Shimizu Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers Int J Radiat Oncol Biol Phys 56 2003 126 135
11. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
12. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
13. R. Timmerman, L. Papiez, and R. McGarry Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer Chest 124 2003 1946 1955
14. M. Uematsu, A. Shioda, and A. Suda Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
15. J. Wulf, K. Baier, and G. Mueller Dose-response in stereotactic irradiation of lung tumors Radiother Oncol 77 2005 83 87
16. B.S. Hoppe, B. Laser, and A.V. Kowalski Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: Who's at risk? Int J Radiat Oncol Biol Phys 72 2008 1283 1286
17. N.E. Dunlap, J. Cai, and G.B. Biedermann Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 76 2010 796 801
18. N. Pettersson, J. Nyman, and K.A. Johansson Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis Radiother Oncol 91 2009 360 368
19. K.L. Stephans, T. Djemil, and C.A. Reddy A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: The Cleveland Clinic experience J Thorac Oncol 4 2009 976 982
20. J.P. Voroney, A. Hope, and M.R. Dahele Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer J Thorac Oncol 4 2009 1035 1037
21. T. Kawase, A. Takeda, and E. Kunieda Extrapulmonary soft-tissue fibrosis resulting from hypofractionated stereotactic body radiotherapy for pulmonary nodular lesions Int J Radiat Oncol Biol Phys 74 2009 349 354
22. http://www.rtog.org/members/protocols/0236/0236.pdf.
23. C. Park, L. Papiez, and S. Zhang Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
24. M.K. Karmakar, and A.M. Ho Postthoracotomy pain syndrome Thorac Surg Clin 14 2004 345 352
25. S.H. Giordano, A. Lee, and Y.F. Kuo Late gastrointestinal toxicity after radiation for prostate cancer Cancer 107 2006 423 432
26. C. Lilla, C.B. Ambrosone, and S. Kropp Predictive factors for late normal tissue complications following radiotherapy for breast cancer Breast Cancer Res Treat 106 2007 143 150